XXII · 22nd Century Group, Inc.

This 8-K discloses the initiation of an at-the-market (ATM) equity offering program, a flexible capital-raising mechanism that allows 22nd Century Group to sell shares incrementally into the market at prevailing prices, minimizing market impact and avoiding fixed pricing or underwriting discounts. The $6.4 million capacity represents a modest but operationally significant funding source relative to the Company’s disclosed share count of ~4.46 million and likely low market capitalization. Because no shares had been sold under the program in the prior 12 months, this filing signals active deployment — potentially to fund ongoing operations, R&D, or regulatory initiatives related to its tobacco science platform. The reliance on an effective S-3 shelf registration confirms the Company maintains current financial reporting and SEC compliance, while Foley & Lardner’s legal opinion mitigates issuance risk by affirming the validity and nonassessability of shares sold. For investors, the primary implication is potential dilution proportional to actual sales volume and timing; however, the absence of forward-looking guidance, use-of-proceeds detail, or financing covenants limits assessment of strategic intent or financial impact magnitude.